These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29162673)

  • 1. Newborn Screening for Pompe Disease.
    Bodamer OA; Scott CR; Giugliani R;
    Pediatrics; 2017 Jul; 140(Suppl 1):S4-S13. PubMed ID: 29162673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease.
    Burton BK; Kronn DF; Hwu WL; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S14-S23. PubMed ID: 29162674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Genetic Counseling in Pompe Disease After Patients Are Identified Through Newborn Screening.
    Atherton AM; Day-Salvatore D;
    Pediatrics; 2017 Jul; 140(Suppl 1):S46-S50. PubMed ID: 29162676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for Pompe disease: an update, 2011.
    Burton BK
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease.
    Davids L; Sun Y; Moore RH; Lisi E; Wittenauer A; Wilcox WR; Ali N
    Mol Genet Metab; 2021; 134(1-2):20-28. PubMed ID: 34602357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum.
    Kronn DF; Day-Salvatore D; Hwu WL; Jones SA; Nakamura K; Okuyama T; Swoboda KJ; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S24-S45. PubMed ID: 29162675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for Pompe disease: Parental experiences and follow-up care for a late-onset diagnosis.
    Prakash S; Penn JD; Jackson KE; Dean LW
    J Genet Couns; 2022 Dec; 31(6):1404-1420. PubMed ID: 35915971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opinions of adults affected with later-onset lysosomal storage diseases regarding newborn screening: A qualitative study.
    Lisi EC; Ali N
    J Genet Couns; 2021 Dec; 30(6):1544-1558. PubMed ID: 33938615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for Pompe disease in Japan.
    Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the Newborn Screening, Diagnosis, and Treatment for Pompe Disease Guidance Supplement.
    Kishnani PS; Hwu WL;
    Pediatrics; 2017 Jul; 140(Suppl 1):S1-S3. PubMed ID: 29162672
    [No Abstract]   [Full Text] [Related]  

  • 12. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations.
    Kemper AR; Hwu WL; Lloyd-Puryear M; Kishnani PS
    Pediatrics; 2007 Nov; 120(5):e1327-34. PubMed ID: 17974725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
    Richardson JS; Kemper AR; Grosse SD; Lam WKK; Rose AM; Ahmad A; Gebremariam A; Prosser LA
    Genet Med; 2021 Apr; 23(4):758-766. PubMed ID: 33281187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public support for neonatal screening for Pompe disease, a broad-phenotype condition.
    Weinreich SS; Rigter T; van El CG; Dondorp WJ; Kostense PJ; van der Ploeg AT; Reuser AJ; Cornel MC; Hagemans ML
    Orphanet J Rare Dis; 2012 Mar; 7():15. PubMed ID: 22413814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases.
    Lisi EC; Gillespie S; Laney D; Ali N
    Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
    Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
    Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening.
    Pillai NR; Fabie NAV; Kaye TV; Rosendahl SD; Ahmed A; Hietala AD; Jorgenson AB; Lanpher BC; Whitley CB
    Mol Genet Metab; 2023; 140(1-2):107633. PubMed ID: 37414610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of multi-generational Pompe disease: Are current practices missing diagnostic and treatment opportunities?
    McIntosh P; Austin S; Sullivan J; Bailey L; Bailey C; Viskochil D; Kishnani PS
    Am J Med Genet A; 2017 Oct; 173(10):2628-2634. PubMed ID: 28763149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for Pompe disease: impact on families.
    Pruniski B; Lisi E; Ali N
    J Inherit Metab Dis; 2018 Nov; 41(6):1189-1203. PubMed ID: 29594646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.
    Rigter T; Weinreich SS; van El CG; de Vries JM; van Gelder CM; Güngör D; Reuser AJ; Hagemans ML; Cornel MC; van der Ploeg AT
    Mol Genet Metab; 2012 Nov; 107(3):448-55. PubMed ID: 23040796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.